Xuben Hou

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Journal of medicinal chemistry

Science advances

Journal of chemical information and modeling

Future medicinal chemistry

Shandong University

Shandong University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shandong University

China

Associate Professor :: School of Pharmaceutical Science

New York University

United States

Postdoctoral research associate :: Chemistry Department

Education History

Shandong University

China

PHD :: School of Pharmaceutical Science

New York University

United States

PHD :: Chemistry Department

Shandong University Sep 01 2007 - Jun 30 2011

China

BSC :: School of Pharmaceutical Science

Publications

Meng Liu, Shan Gao, Yong Wang, Xinying Yang, Hao Fang, Xuben Hou
Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death. Journal of medicinal chemistry (2024)
Yingjie Chang, Huahui Guo, Xue Li, Liangyi Zong, Jiale Wei, Zhihai Li, Cheng Luo, Xinying Yang, Hao Fang, Xiang-Qian Kong, Xuben Hou
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity. Journal of medicinal chemistry (2024)
Zhiyuan Zhao, Jintong Du, Yu Du, Yuan Gao, Mingxuan Yu, Yingkai Zhang, Hao Fang, Xuben Hou
Deciphering the Allosteric Activation Mechanism of SIRT6 Using Molecular Dynamics Simulations. Journal of chemical information and modeling (2023)
Wenqiang Chang, Ming Zhang, Xueyang Jin, Haijuan Zhang, Hongbo Zheng, Sha Zheng, Yanan Qiao, Haina Yu, Bin Sun, Xuben Hou, Hong-Xiang Lou
Inhibition of fungal pathogenicity by targeting the H 2 S-synthesizing enzyme cystathionine β-synthase. Science advances 8 (50) (2022)
Meng Liu, Shan Gao, Tao Liang, Xueting Qiu, Xinying Yang, Hao Fang, Xuben Hou
Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity. Journal of medicinal chemistry 65 (18) (2022)
Wenqiang Chang, Ming Zhang, Xueyang Jin, Haijuan Zhang, Hongbo Zheng, Sha Zheng, Yanan Qiao, Haina Yu, Bin Sun, Xuben Hou, Hong-Xiang Lou
Inhibition of fungal pathogenicity by targeting the H 2 S-synthesizing enzyme cystathionine β-synthase. Science advances 8 (50) (2022)
Wenqiang Chang, Ming Zhang, Xueyang Jin, Haijuan Zhang, Hongbo Zheng, Sha Zheng, Yanan Qiao, Haina Yu, Bin Sun, Xuben Hou, Hong-Xiang Lou
Inhibition of fungal pathogenicity by targeting the H 2 S-synthesizing enzyme cystathionine β-synthase. Science advances 8 (50) (2022)
Chen Chen, Xue Li, Huajun Zhao, Meng Liu, Jintong Du, Jian Zhang, Xinying Yang, Xuben Hou, Hao Fang
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity. Journal of medicinal chemistry 65 (4) (2022)
Wenqiang Chang, Ming Zhang, Xueyang Jin, Haijuan Zhang, Hongbo Zheng, Sha Zheng, Yanan Qiao, Haina Yu, Bin Sun, Xuben Hou, Hong-Xiang Lou
Inhibition of fungal pathogenicity by targeting the H 2 S-synthesizing enzyme cystathionine β-synthase. Science advances 8 (50) (2022)
Wenqiang Chang, Ming Zhang, Xueyang Jin, Haijuan Zhang, Hongbo Zheng, Sha Zheng, Yanan Qiao, Haina Yu, Bin Sun, Xuben Hou, Hong-Xiang Lou
Inhibition of fungal pathogenicity by targeting the H 2 S-synthesizing enzyme cystathionine β-synthase. Science advances 8 (50) (2022)
Yi Zhou, Xiaoting Liu, Junxin Xue, Lulu Liu, Tao Liang, Wen Li, Xinying Yang, Xuben Hou, Hao Fang
Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma. Journal of medicinal chemistry 63 (9) (2020)
Tao Liang, Yi Zhou, Reham M Elhassan, Xuben Hou, Xinying Yang, Hao Fang
HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells. Journal of medicinal chemistry 63 (20) (2020)
Wen Li, Reham M Elhassan, Hao Fang, Xuben Hou
Photopharmacology-based small-molecule proteolysis targeting chimeras: optical control of protein degradation. Future medicinal chemistry 12 (22) (2020)
Jintong Du, Lulu Liu, Bo Liu, Jing Yang, Xuben Hou, Jinming Yu, Hao Fang
Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors. Future medicinal chemistry 12 (14) (2020)
Jianing Lu, Xuben Hou, Cheng Wang, Yingkai Zhang
Incorporating Explicit Water Molecules and Ligand Conformation Stability in Machine-Learning Scoring Functions. Journal of chemical information and modeling 59 (11) (2019)
Xuben Hou, David Rooklin, Duxiao Yang, Xiao Liang, Kangshuai Li, Jianing Lu, Cheng Wang, Peng Xiao, Yingkai Zhang, Jin-Peng Sun, Hao Fang
Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors. Journal of chemical information and modeling 58 (11) (2018)

Xuben Hou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xuben Hou